Extracellular vesicles produced by a large-scale protocol are therapeutically effective in preclinical model of Parkinson’s disease
Agnė Pociūtė(Ikerbasque), Augustas Pivoriūnas(Ikerbasque), Marianne Pultar(Mirna Therapeutics (United States)), Baiba Jansone(University of Latvia), Vladimirs Piļipenko(University of Latvia), Virginijus Tunaitis(State Research Institute Centre for Innovative Medicine), Matthias Hackl(Mirna Therapeutics (United States)), Arunas Zebrauskas(State Research Institute Centre for Innovative Medicine), Karīna Narbute(Latvian Biomedical Research and Study Centre)
Cited by 0
Related Papers
Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue–Derived Mesenchymal Stem Cells In Vitro
|Journal of Bone and Mineral Research|2016|130
Astrocytes dynamically regulate the blood-brain barrier in the healthy brain
|Neural Regeneration Research|2023|20
Concentration‐dependent duality of bFGF in regulation of barrier properties of human brain endothelial cells
|Journal of Cellular Physiology|2021|12
Basic Fibroblast Growth Factor Opens and Closes the Endothelial Blood–Brain Barrier in a Concentration-Dependent Manner
|Neurochemical Research|2022|5